First human trial tests partial reprogramming to reverse aging in glaucoma
TL;DR
Scientists have treated the first participant in an early-stage clinical trial testing partial cellular reprogramming to make aging cells act younger, aiming to regenerate optic nerve neurons in glaucoma. While promising, the approach is experimental, enrolling up to 12 participants, with potential cancer risk, and is not a universal anti-aging therapy.
- Scientists begin first trial to reverse human aging Yahoo
- Turning Back the (Biological) Clock theSkimm
- Scientists test first-ever therapy to make human cells young again NewsNation
- First ‘cell rejuvenation’ therapy in humans: Can ageing finally be treated? The Times of India
- Longevity Science Splits Between Promising Research and “Miracle” Claims tovima.com
Want the full story? Read the original reporting
Read on Yahoo